Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Cardiology|July 13, 1999
Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular diseaseJ A Papadakis, E S Ganotakis, I A Jagroop, et al.
Platelets|June 24, 2006
Platelet activation and serotonin release during colorectal surgeryA Fawcett, A Jagroop, M Sian, et al.
American Journal of Hypertension|July 20, 1999
Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemiaJ A Papadakis, E S Ganotakis, I A Jagroop, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|May 7, 2002
The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT)F Youssef, A M Seifalian, I A Jagroop, et al.
International Angiology : a Journal of the International Union of Angiology|April 16, 1999
Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle adviceD P Mikhailidis, E S Ganotakis, K A Spyropoulos, et al.
Platelets|November 26, 2005
Does meta-chlorophenylpiperazine (mCPP) activate human platelets?A E Frampton, J C H Andrews, A Parfitt, et al.
Journal of Clinical Pathology|March 29, 2002
Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular riskD J Byrne, I A Jagroop, H E Montgomery, et al.
International Angiology : a Journal of the International Union of Angiology|September 27, 2001
Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction. A preliminary studyM E Sullivan, M A Miller, C R Bell, et al.
Angiology|August 26, 2003
The effects of transdermal estradiol alone or with cyclical dydrogesterone on markers of cardiovascular disease risk in postmenopausal women with type 2 diabetes: a pilot studyN D Stojanovic, P Kwong, D J Byrne, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen geneH E Montgomery, P Clarkson, O M Nwose, et al.
Pageof 2